Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Stoss therapy is safe for treatment of vitamin D deficiency in pediatric patients undergoing HSCT

Abstract

Vitamin D deficiency remains common among pediatric patients undergoing hematopoietic stem cell transplant (HSCT) despite both aggressive and standard of care strategies. This study examined the safety and efficacy of single high-dose oral vitamin D therapy (Stoss therapy) for treatment of vitamin D deficiency in HSCT recipients. Patients ages 1–21 years presenting for HSCT were randomized to receive either Stoss regimen plus weekly/daily supplementation or standard of care, per US Endocrine Society guidelines. Among the total 48 subjects, 22 (46%) were randomized to Stoss and 26 (54%) to control arms. Baseline 25-hydroxyvitamin D (25-OHD) levels were insufficient/deficient in total of 34 (71%) patients, without difference between treatment groups. The Stoss regimen was well tolerated and no toxicity was observed. At Day +30, mean 25-OHD levels were significantly higher (P = 0.04) with Stoss (42.3 ± 12 μg/l) compared to controls (35.6 ± 14.3 μg/l), and a higher proportion of Stoss patients had adequate vitamin D levels than controls (85% vs 65%). Stoss therapy is a safe and efficacious treatment option for vitamin D deficiency in children undergoing HSCT and may achieve sufficient levels more rapidly than standard of care. This trial was registered at www.clinicaltrials.gov as NCT03176849.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Design and recruitment of pediatric patients presenting for HSCT in the randomized controlled study of Stoss regimen.
Fig. 2: Vitamin D levels in the both arms.
Fig. 3: Toxicity related to hypervitaminosis D.

Similar content being viewed by others

References

  1. Campos DJ, Boguszewski CL, Funke VA, Bonfim CM, Kulak CA, Pasquini R, et al. Bone mineral density, vitamin D, and nutritional status of children submitted to hematopoietic stem cell transplantation. Nutrition. 2014;30:654–9.

    Article  Google Scholar 

  2. Duncan CN, Vrooman L, Apfelbaum EM, Whitley K, Bechard L, Lehmann LE. 25-hydroxy vitamin D deficiency following pediatric hematopoietic stem cell transplant. Biol Blood Marrow Transpl. 2011;17:749–53.

    Article  CAS  Google Scholar 

  3. Wallace G, Jodele S, Howell J, Myers KC, Teusink A, Zhao X, et al. Vitamin D deficiency and survival in children after hematopoietic stem cell transplant. Biol Blood Marrow Transpl. 2015;21:1627–31.

    Article  CAS  Google Scholar 

  4. Wallace G, Jodele S, Myers KC, Dandoy CE, El-Bietar J, Nelson A, et al. Vitamin D deficiency in pediatric hematopoietic stem cell transplantation patients despite both standard and aggressive supplementation. Biol Blood Marrow Transpl. 2016;22:1271–4.

    Article  CAS  Google Scholar 

  5. Bechard LJ, Gordon C, Feldman HA, Venick R, Gura K, Guinan EC, et al. Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation. Pediatr Blood Cancer. 2015;62:687–92.

    Article  CAS  Google Scholar 

  6. Beebe K, Magee K, McNulty A, Stahlecker J, Salzberg D, Miller H, et al. Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2017;65:e26817.

    Article  Google Scholar 

  7. Stein EM, Shane E. Vitamin D in organ transplantation. Osteoporos Int. 2011;22:2107–18.

    Article  CAS  Google Scholar 

  8. Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley JF, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med. 1999;131:738–44.

    Article  CAS  Google Scholar 

  9. von Bahr L, Blennow O, Alm J, Bjorklund A, Malmberg KJ, Mougiakakos D, et al. Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. Bone Marrow Transpl. 2015;50:1217–23.

    Article  Google Scholar 

  10. Sproat L, Bolwell B, Rybicki L, Dean R, Sobecks R, Pohlman B, et al. Vitamin D level after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transpl. 2011;17:1079–83.

    Article  CAS  Google Scholar 

  11. Glotzbecker B, Ho VT, Aldridge J, Kim HT, Horowitz G, Ritz J, et al. Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD. Bone Marrow Transpl. 2013;48:593–7.

    Article  CAS  Google Scholar 

  12. Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, et al. Immunomodulatory effects of vitamin D: Implications for GVHD. Bone Marrow Transplant. 2010;45:1463–8.

    Article  CAS  Google Scholar 

  13. Caballero-Velazquez T, Montero I, Sanchez-Guijo F, Parody R, Saldana R, Valcarcel D, et al. Immunomodulatory effect of vitamin D after allogeneic stem cell transplantation: results of a prospective multicenter clinical trial. Clin Cancer Res. 2016;22:5673–81.

    Article  CAS  Google Scholar 

  14. Henden AS, Hill GR. Cytokines in graft-versus-host disease. J Immunol. 2015;194:4604–12.

    Article  CAS  Google Scholar 

  15. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984;3:1451–5.

    Article  Google Scholar 

  16. GO H. [Die Stossprophylaxe der rachitis]. Dtsch Med Wochenschr. 1938;64:1835–7. [Article in German].

    Article  Google Scholar 

  17. Shah BRFL. Single-day therapy for nutritional vitamin D-deficiency rickets: a preferred method. J Pediatr Endocrinol Metab. 1994;125:487–90.

    CAS  Google Scholar 

  18. Cesur Y, Caksen H, Gündem A, Kirmi E, Odabaş D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab. 2003;16:1105–9.

    Article  CAS  Google Scholar 

  19. Shepherd D, Belessis Y, Katz T, Morton J, Field P, Jaffe A. Single high-dose oral vitamin D3 (stoss) therapy-a solution to vitamin D deficiency in children with cystic fibrosis?. J Cyst Fibros. 2013;12:177–82.

    Article  CAS  Google Scholar 

  20. Shepherd DDA, Leach ST, Lopez R, Messenger R, Woodhead HJ, Ledder O, et al. Single high-dose oral vitamin D3 therapy (Stoss): a solution to vitamin D deficiency in children with inflammatory bowel disease? J Pediatr Gastroenterol Nutr. 2015;61:411–4.

    Article  CAS  Google Scholar 

  21. Koçyiğit CÇG, İnce G, Özkan EB, Dündar BN. Can Stoss therapy be used in children with vitamin D deficiency or insufficiency without rickets? J Clin Res Pediatr Endocrinol. 2017;9:150–5.

    Article  Google Scholar 

  22. Wallace G, Jodele S, Myers KC, Dandoy CE, El-Bietar J, Nelson A, et al. Single ultra-high-dose cholecalciferol to prevent vitamin D deficiency in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2018;24:1856–60.

    Article  CAS  Google Scholar 

  23. Michael F, Holick NCB, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.

    Article  Google Scholar 

  24. Sylvia Christakos PD, Porta A, Mady LJ, Seth T. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol. 2011;347:25–9.

    Article  Google Scholar 

  25. Fukumoto S. Phosphate metabolism and vitamin D. Bonekey Rep. 2014;3:497. https://doi.org/10.1038/bonekey.2013.231.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ilahi M, Armas LAG, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87:688–91.

    Article  CAS  Google Scholar 

  27. Davies JH, Evans BAJ, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Child. 2005;90:373–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank research coordinators Kayla Burgett, Kara Kronemeyer, and Jessica Cline, who collected the data for the trial.

Funding

Grants from the Learners Research Fund, Phoenix Children’s Hospital and Valley Research Partnership Grant (P1201707), University of Arizona, provided support for the trial.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Ngwube.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bodea, J., Beebe, K., Campbell, C. et al. Stoss therapy is safe for treatment of vitamin D deficiency in pediatric patients undergoing HSCT. Bone Marrow Transplant 56, 2137–2143 (2021). https://doi.org/10.1038/s41409-021-01294-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-021-01294-x

Search

Quick links